A Phase I Trial of Ribavirin and Low-Dose Cytarabine for the Treatment of Relapsed and Refractory Acute Myeloid Leukemia With Elevated eIF4E

Haematologica- Italy

doi 10.3324/haematol.2014.111245

Full Text

Abstract

Available in

Categories

Hematology

Date

Authors

Publisher

Ferrata Storti Foundation (Haematologica)


Related search